← back to search

Edmund Lau

The University of Sydney · AU
Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Chronic Obstructive Pulmonary Disease (COPD) Research, and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
h-index
34
citations
5,388
works
198
NIH funding
primary concept
email

Recent publications

Real‐world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real‐world Evidence Working Group
Pulmonary Circulation 2023cited by 4position: middledoi
Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia
JACC Asia 2022cited by 65position: lastdoi
Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort
Respiration 2021cited by 20position: middledoi
Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry
Respirology 2020cited by 86position: lastdoi
Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features. Further Lessons from COLDICE, a Prospective Multicenter Clinical Trial
American Journal of Respiratory and Critical Care Medicine 2020cited by 60position: middledoi
Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study
The Lancet Respiratory Medicine 2019cited by 387position: middledoi
Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease
Respirology 2019cited by 62position: middledoi
Epidemiology and treatment of pulmonary arterial hypertension
Nature Reviews Cardiology 2017cited by 499position: firstdoi
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
The Lancet Respiratory Medicine 2017cited by 177position: middledoi
Respiratory effects of trichloroethylene
Respiratory Medicine 2017cited by 59position: middledoi
Pathophysiology of exercise intolerance in pulmonary arterial hypertension
Respirology 2017cited by 53position: middledoi
Pulmonary veno-occlusive disease
European Respiratory Journal 2016cited by 505position: middledoi
Resting pulmonary artery pressure of 21–24 mmHg predicts abnormal exercise haemodynamics
European Respiratory Journal 2016cited by 51position: firstdoi
Criteria for diagnosis of exercise pulmonary hypertension
European Respiratory Journal 2015cited by 248position: middledoi
Pulmonary vascular resistance and compliance relationship in pulmonary hypertension
European Respiratory Journal 2015cited by 129position: middledoi
Genetic counselling in a national referral centre for pulmonary hypertension
European Respiratory Journal 2015cited by 110position: middledoi
The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress
European Respiratory Journal 2015cited by 79position: firstdoi
Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease
CHEST Journal 2015cited by 72position: firstdoi
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Circulation 2014cited by 334position: middledoi
Chemotherapy-Induced Pulmonary Hypertension
American Journal Of Pathology 2014cited by 209position: middledoi
Early detection of pulmonary arterial hypertension
Nature Reviews Cardiology 2014cited by 135position: firstdoi
Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension
European Respiratory Journal 2014cited by 78position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marc Humbert · Médecins Sans Frontières11 papers (2014–2017)Olivier Sitbon · Médecins Sans Frontières9 papers (2014–2017)David Montani · Médecins Sans Frontières9 papers (2014–2017)Xavier Jaïs · Inserm8 papers (2014–2017)Gérald Simonneau · Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique8 papers (2014–2017)David S. Celermajer · The University of Notre Dame Australia7 papers (2014–2020)Laurent Savale · Centre d'Épidémiologie sur les Causes Médicales de Décès7 papers (2014–2017) · 4 papers (2015–2016)Laurent Godinas · KU Leuven4 papers (2015–2016) · 4 papers (2015–2016)Florence Parent · Inserm4 papers (2015–2017)Paul J. Torzillo · The University of Sydney3 papers (2014–2020)Tamera J. Corte · The University of Sydney3 papers (2019–2021)Peter Dorfmüller · Justus-Liebig-Universität Gießen3 papers (2014–2017)Sven Günther · Inserm3 papers (2014–2016) · 3 papers (2015–2017)Frédéric Perros · Université Claude Bernard Lyon 13 papers (2014–2017)Lauren Troy · The University of Sydney3 papers (2019–2021) · 3 papers (2015–2017)Yuichi Tamura · Design Intelligence (United States)2 papers (2015–2015)